These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 25746122)

  • 1. Amphiphilic polyelectrolyte/prodrug nanoparticles constructed by synergetic electrostatic and hydrophobic interactions with cooperative pH-sensitivity for controlled doxorubicin delivery.
    Huang P; Wang W; Zhou J; Zhao F; Zhang Y; Liu J; Liu J; Dong A; Kong D; Zhang J
    ACS Appl Mater Interfaces; 2015 Mar; 7(11):6340-50. PubMed ID: 25746122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pH-sensitive charge-conversion system for doxorubicin delivery.
    Guan X; Li Y; Jiao Z; Chen J; Guo Z; Tian H; Chen X
    Acta Biomater; 2013 Aug; 9(8):7672-8. PubMed ID: 23648572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione- and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy.
    Xu Z; Liu S; Kang Y; Wang M
    Nanoscale; 2015 Mar; 7(13):5859-68. PubMed ID: 25757484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
    Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
    Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembled Monomethoxy (Polyethylene Glycol)-b-P(D,L-Lactic-co-Glycolic Acid)-b-P(L-Glutamic Acid) Hybrid-Core Nanoparticles for Intracellular pH-Triggered Release of Doxorubicin.
    Xu H; Cai C; Gou J; Sui B; Jin J; Xu H; Zhang Y; Wang L; Zhai Y; Tang X
    J Biomed Nanotechnol; 2015 Aug; 11(8):1354-69. PubMed ID: 26295138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-sensitive micelles self-assembled from multi-arm star triblock co-polymers poly(ε-caprolactone)-b-poly(2-(diethylamino)ethyl methacrylate)-b-poly(poly(ethylene glycol) methyl ether methacrylate) for controlled anticancer drug delivery.
    Yang YQ; Zhao B; Li ZD; Lin WJ; Zhang CY; Guo XD; Wang JF; Zhang LJ
    Acta Biomater; 2013 Aug; 9(8):7679-90. PubMed ID: 23669619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrin-targeted zwitterionic polymeric nanoparticles with acid-induced disassembly property for enhanced drug accumulation and release in tumor.
    Huang P; Song H; Wang W; Sun Y; Zhou J; Wang X; Liu J; Liu J; Kong D; Dong A
    Biomacromolecules; 2014 Aug; 15(8):3128-38. PubMed ID: 25054812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and paclitaxel by PEG-polypeptide nanovehicle for the treatment of non-small cell lung cancer.
    Lv S; Tang Z; Li M; Lin J; Song W; Liu H; Huang Y; Zhang Y; Chen X
    Biomaterials; 2014 Jul; 35(23):6118-29. PubMed ID: 24794923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
    Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
    J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy.
    Zhang J; Tao W; Chen Y; Chang D; Wang T; Zhang X; Mei L; Zeng X; Huang L
    J Mater Sci Mater Med; 2015 Apr; 26(4):165. PubMed ID: 25791459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zwitterionic nanoparticles constructed with well-defined reduction-responsive shell and pH-sensitive core for "spatiotemporally pinpointed" drug delivery.
    Huang P; Liu J; Wang W; Li C; Zhou J; Wang X; Deng L; Kong D; Liu J; Dong A
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):14631-43. PubMed ID: 25100635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Responsive Nanoscale Coordination Polymer for Efficient Drug Delivery and Real-Time Release Monitoring.
    Han K; Zhang WY; Zhang J; Ma ZY; Han HY
    Adv Healthc Mater; 2017 Oct; 6(19):. PubMed ID: 28714280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of self-assembled, pH-responsive nanoparticles of mPEGylated peptide dendron-doxorubicin conjugates for cancer therapy.
    She W; Luo K; Zhang C; Wang G; Geng Y; Li L; He B; Gu Z
    Biomaterials; 2013 Feb; 34(5):1613-23. PubMed ID: 23195490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
    Raja MA; Arif M; Feng C; Zeenat S; Liu CG
    J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid lipid-capped mesoporous silica for stimuli-responsive drug release and overcoming multidrug resistance.
    Han N; Zhao Q; Wan L; Wang Y; Gao Y; Wang P; Wang Z; Zhang J; Jiang T; Wang S
    ACS Appl Mater Interfaces; 2015 Feb; 7(5):3342-51. PubMed ID: 25584634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activable Cell-Penetrating Peptide Conjugated Prodrug for Tumor Targeted Drug Delivery.
    Cheng H; Zhu JY; Xu XD; Qiu WX; Lei Q; Han K; Cheng YJ; Zhang XZ
    ACS Appl Mater Interfaces; 2015 Jul; 7(29):16061-9. PubMed ID: 26161578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-b-PCL copolymer micelles with the ability of pH-controlled negative-to-positive charge reversal for intracellular delivery of doxorubicin.
    Deng H; Liu J; Zhao X; Zhang Y; Liu J; Xu S; Deng L; Dong A; Zhang J
    Biomacromolecules; 2014 Nov; 15(11):4281-92. PubMed ID: 25325531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Codelivery of antitumor drug and gene by a pH-sensitive charge-conversion system.
    Guan X; Li Y; Jiao Z; Lin L; Chen J; Guo Z; Tian H; Chen X
    ACS Appl Mater Interfaces; 2015 Feb; 7(5):3207-15. PubMed ID: 25581567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.